Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for phantom limb pain after amputation in bone tumor patients
ChiCTR1900027038Phase 4Recruiting
- Sponsor
- Cancer Hospital of China Medical University
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of duloxetine in phantom limb pain (PLP) (2 arms), sponsored by Cancer Hospital of China Medical University. Primary endpoint: Numeric Rating Scale pain score. Started Nov 2019; status: recruiting.
02
Drugs
duloxetine
03
Conditions
phantom limb pain (PLP)
Beyond the preview
Go deeper on ChiCTR1900027038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027038.